CLPUB00126
Yasumura Y., Kawakita Y.
Studies on SV40 in tissue culture: preliminary step for cancer research in vitro.
Nihon Rinsho 21:1201-1219(1963)

PubMed=6027511; DOI=10.3181/00379727-125-32029
Simizu B., Rhim J.S., Wiebenga N.H.
Characterization of the Tacaribe group of arboviruses. I. Propagation and plaque assay of Tacaribe virus in a line of African green monkey kidney cells (Vero).
Proc. Soc. Exp. Biol. Med. 125:119-123(1967)

DOI=10.1007/BF02618370
Stulberg C.S., Coriell L.L., Kniazeff A.J., Shannon J.E.
The animal cell culture collection.
In Vitro 5:1-16(1970)

PubMed=6298990; DOI=10.1016/0378-1135(82)90056-6
McPhee D.A., Parsonson I.M., Della-Porta A.J.
Comparative studies on the growth of Australian bluetongue virus serotypes in continuous cell lines and embryonated chicken eggs.
Vet. Microbiol. 7:401-410(1982)

PubMed=4043530
Whitaker A.M., Hayward C.J.
The characterization of three monkey kidney cell lines.
Dev. Biol. Stand. 60:125-131(1985)

CLPUB00328
Earley E.M., Johnson K.M.
The lineage of Vero, Vero 76 and its clone C1008 in the United States.
(In) Vero cells: origin, properties and biomedical applications; Simizu B., Terasima T. (eds.); pp.26-29; Department of Microbiology School of Medicine Chiba University; Chiba (1988)

PubMed=2260226
Tsareva A.A., Isaenko A.A., Urmanova M.A., Yurchenko N.D., Balzovskaia E.G., Rodionova O.M.
A karyotype study of the Vero cell line cultured long term in a monolayer by static and roller methods.
Tsitologiia 32:741-748(1990)

PubMed=10403033; DOI=10.1006/biol.1998.0156
Lang J., Cetre J.C., Picot N., Lanta M., Briantais P., Vital S., Le Mener V., Lutsch C., Rotivel Y.
Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
Biologicals 26:299-308(1998)

PubMed=10494966
Montagnon B.J., Vincent-Falquet J.-C., Saluzzo J.-F.
Experience with Vero cells at Pasteur Merieux Connaught.
Dev. Biol. Stand. 98:137-140(1999)

PubMed=12667817; DOI=10.1016/S0042-6822(02)00064-8
Romanova J., Katinger D., Ferko B., Voglauer R., Mochalova L., Bovin N., Lim W., Katinger H., Egorov A.
Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern.
Virology 307:90-97(2003)

PubMed=16494729; DOI=10.3201/eid1201.050496
Kaye M., Druce J., Tran T., Kostecki R., Chibo D., Morris J., Catton M., Birch C.
SARS-associated coronavirus replication in cell lines.
Emerg. Infect. Dis. 12:128-133(2006)

DOI=10.12665/J63.Morgan
Morgan J.H.
Vero cells in vaccine production.
BioProcess. J. 6:12-17(2007)

PubMed=19016439; DOI=10.1002/9780471729259.mca04es11
Ammerman N.C., Beier-Sexton M., Azad A.F.
Growth and maintenance of Vero cell lines.
Curr. Protoc. Microbiol. 11:A.4E.1-A.4E.7(2008)

PubMed=19768803; DOI=10.1002/btpr.279
Rourou S., van der Ark A., van der Velden T., Kallel H.
Development of an animal-component free medium for Vero cells culture.
Biotechnol. Prog. 25:1752-1761(2009)

PubMed=19941903; DOI=10.1016/j.jviromet.2009.11.022
Karger A., Bettin B., Lenk M., Mettenleiter T.C.
Rapid characterisation of cell cultures by matrix-assisted laser desorption/ionisation mass spectrometric typing.
J. Virol. Methods 164:116-121(2010)

PubMed=22059503; DOI=10.1186/1472-6750-11-102
Almeida J.L., Hill C.R., Cole K.D.
Authentication of African green monkey cell lines using human short tandem repeat markers.
BMC Biotechnol. 11:102.1-102.10(2011)

PubMed=24975811; DOI=10.1016/j.vaccine.2014.06.045
Donis R.O., Chen L.-M., Davis C.T., Foust A., Hossain M.J., Johnson A., Klimov A., Loughlin R.F., Xu X.-Y., Tsai T., Blayer S., Trusheim H., Colegate T., Fox J., Taylor B., Hussain A.I., Barr I., Baas C., Louwerens J., Geuns E., Lee M.-S., Venhuizen L., Neumeier E., Ziegler T.
Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.
Vaccine 32:6583-6590(2014)

PubMed=25267831; DOI=10.1093/dnares/dsu029
Osada N., Kohara A., Yamaji T., Hirayama N., Kasai F., Sekizuka T., Kuroda M., Hanada K.
The genome landscape of the African green monkey kidney-derived Vero cell line.
DNA Res. 21:673-683(2014)

PubMed=25903999; DOI=10.1002/biot.201400388
Genzel Y.
Designing cell lines for viral vaccine production: where do we stand?
Biotechnol. J. 10:728-740(2015)

PubMed=28386771; DOI=10.1007/s10616-017-0082-7
Andreani N.A., Renzi S., Piovani G., Ajmone-Marsan P., Bomba L., Villa R., Ferrari M., Dotti S.
Potential neoplastic evolution of Vero cells: in vivo and in vitro characterization.
Cytotechnology 69:741-750(2017)

PubMed=32376603; DOI=10.1126/science.abc1932
Gao Q., Bao L.-L., Mao H.-Y., Wang L., Xu K.-W., Yang M.-N., Li Y.-J., Zhu L., Wang N., Lv Z., Gao H., Ge X.-Q., Kan B., Hu Y.-L., Liu J.-N., Cai F., Jiang D.-Y., Yin Y.-H., Qin C.-F., Li J., Gong X.-J., Lou X.-Y., Shi W., Wu D.-D., Zhang H.-M., Zhu L., Deng W., Li Y.-R., Lu J.-X., Li C.-G., Wang X.-X., Yin W.-D., Zhang Y.-J., Qin C.
Development of an inactivated vaccine candidate for SARS-CoV-2.
Science 369:77-81(2020)

PubMed=32511316; DOI=10.1101/2020.03.02.972935
Harcourt J.L., Tamin A., Lu X.-Y., Kamili S., Kumar-Sakthivel S., Murray J., Queen K., Tao Y., Paden C.R., Zhang J., Li Y., Uehara A., Wang H.-B., Goldsmith C., Bullock H.A., Wang L.-J., Whitaker B., Lynch B., Gautam R., Schindewolf C., Lokugamage K.G., Scharton D., Plante J.A., Mirchandani D., Widen S.G., Narayanan K., Makino S., Ksiazek T.G., Plante K.S., Weaver S.C., Lindstrom S., Tong S.-X., Menachery V.D., Thornburg N.J.
Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient.
bioRxiv 2020:972935-972935(2020)

PubMed=33389257; DOI=10.1007/s10096-020-04106-0
Wurtz N., Penant G., Jardot P., Duclos N., La Scola B.
Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile.
Eur. J. Clin. Microbiol. Infect. Dis. 40:477-484(2021)